Autoclavable pharmaceutical compositions containing a chelating agent
AssigneeNovartis AG
InventorsGyorgy Lajos Kis, Marcia Johanna Adam, Andrea Fetz
Life of this patent
Estimating the term…
Abstract
Disclosed are ophthalmic compositions comprising ketotifen and pharmaceutically acceptable salts thereof, as well as methods for making such compositions.
Claims14
An ophthalmic pharmaceutical composition consisting essentially of 0.0345% ketotifen hydrogen fumarate, 2.125% glycerol, 0.01% benzalkonium chloride, and water.
A method for making an ophthalmic pharmaceutical composition, comprising admixing the non-aqueous components ketotifen hydrogen fumarate, glycerol, and benzalkonium chloride with water such that a final concentration of the non-aqueous components is 0.0345% ketotifen hydrogen fumarate, 2.125% glycerol, and 0.01% benzalkonium chloride.
Dependencies are inferred from the claim text.